Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2

NCT05138263 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05138263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05138263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's disease2
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2022
Completion date
September 30, 2027
Enrollment
640 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment